Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:05 pm Purchase |
2024-12-31 | 13G | Theravance Biopharma, Inc. TBPH |
Newtyn Management, LLC | 4,757,403 9.700% |
657,403 (+16.03%) |
Filing History |
| 2025-02-14 4:05 pm Sale |
2024-12-31 | 13G | BV Financial, Inc. BVFL |
Newtyn Management, LLC | 0 0.000% |
-682,980 (Position Closed) |
Filing History |
| 2025-01-07 5:20 pm Purchase |
2024-11-18 | 13G | Inflection Point Acquisition Corp. II IPXX |
Newtyn Management, LLC | 700,000 8.300% |
700,000 (New Position) |
Filing History |
| 2024-11-14 4:05 pm Purchase |
2024-09-30 | 13G | City Office REIT, Inc. CIO |
Newtyn Management, LLC | 3,938,000 9.800% |
734,758 (+22.94%) |
Filing History |
| 2024-11-14 4:05 pm Unchanged |
2024-09-30 | 13G | Tectonic Therapeutic, Inc. TECX |
Newtyn Management, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-14 4:05 pm Purchase |
2024-09-30 | 13G | Franklin Street Properties Corp. FSP |
Newtyn Management, LLC | 7,150,000 6.900% |
7,150,000 (New Position) |
Filing History |
| 2024-11-14 4:05 pm Sale |
2024-09-30 | 13G | BV Financial, Inc. BVFL |
Newtyn Management, LLC | 682,980 5.800% |
-317,020 (-31.70%) |
Filing History |
| 2024-08-16 4:05 pm Purchase |
2024-08-07 | 13G | Theravance Biopharma, Inc. TBPH |
Newtyn Management, LLC | 4,100,000 8.400% |
4,100,000 (New Position) |
Filing History |
| 2024-03-08 4:05 pm Purchase |
2024-02-28 | 13G | Veradigm Inc. MDRX |
Newtyn Management, LLC | 10,500,000 9.600% |
10,500,000 (New Position) |
Filing History |
| 2024-03-07 6:00 pm Sale |
2024-03-05 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,242,245 4.950% |
-214,428 (-14.72%) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | AVROBIO, Inc. AVRO |
Newtyn Management, LLC | 227,848 6.100% |
227,848 (New Position) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | CYTEIR THERAPEUTICS INC CYTT |
Newtyn Management, LLC | 3,021,500 8.400% |
3,021,500 (New Position) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | City Office REIT, Inc. CIO |
Newtyn Management, LLC | 3,203,242 8.000% |
3,203,242 (New Position) |
Filing History |
| 2024-02-14 4:05 pm Purchase |
2023-12-31 | 13G | BV Financial, Inc. BVFL |
Newtyn Management, LLC | 1,000,000 8.800% |
1,000,000 (New Position) |
Filing History |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | PACIFIC GAS & ELEC CO 6 PR PCGPRA |
Newtyn Management, LLC | 0 0.000% |
-665,610 (Position Closed) |
Filing History |
| 2024-02-13 5:34 pm Sale |
2024-02-09 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,456,673 5.830% |
-277,485 (-16.00%) |
Filing History |
| 2024-01-25 4:05 pm Purchase |
2023-01-17 | 13D | Merrimack Pharmaceuticals, Inc. MACK |
Newtyn Management, LLC | 1,873,694 13.100% |
354,587 (+23.34%) |
Filing History |
| 2023-11-03 5:03 pm Purchase |
2023-10-25 | 13D | Sensei Biotherapeutics, Inc. SNSE |
Newtyn Management, LLC | 1,734,158 6.500% |
1,734,158 (New Position) |
Filing History |
| 2023-05-23 4:05 pm Sale |
2023-05-19 | 13G | PACIFIC GAS & ELEC CO 6 PR PCGPRA |
Newtyn Management, LLC | 665,610 6.500% |
-583,164 (-46.70%) |
Filing History |
| 2023-02-14 4:06 pm Purchase |
2022-12-31 | 13G | PFSweb, Inc. PFSW |
Newtyn Management, LLC | 1,206,502 5.300% |
1,206,502 (New Position) |
Filing History |